Managed Care Hemo

National Hemophilia Foundation

Website provided by National Hemophilia Foundation and its education partners

Tag

Hemophilia Education for Managed Care and Payer Professionals

CME/CE


Hemophilia Clinical Updates and Cost Management Solutions – Certified for Nurses, Pharmacists, and Physicians

Up to  1.25 credit hour available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

  • Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
  • Review alignment of recently approved therapies in the current hemophilia treatment algorithm
  • Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
  • Apply processes for managed care and specialty pharmacy professionals to improve communications and collaborations with HTCs

Expert Faculty

Shannon Carpenter, MD, MS
Professor of Pediatrics, UMKC School of Medicine Hematology/Oncology, Director Kansas City Regional Hemophilia Treatment Center
Director, Anticoagulation Management Program
Children’s Mercy Hospital


Jeffrey Dunn, PharmD, MBA
Vice President, Clinical Strategy and Programs and Industry Relations
Magellan Rx Management

Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/clinical-updates-cost-management-solutions-ce/

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Shire, now part of Takeda.


Latest Hemophilia Insights – Certified for Nurses, Pharmacists, and Physicians

Up to  1.0 credit hour available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

  • Describe recent insights into the safety, efficacy and attributes of recently approved and emerging hemophilia treatment options.
  • Review alignment of recently approved therapies in the current hemophilia treatment algorithm.
  • Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences.
  • Apply processes for managed care organizations and specialty pharmacy providers to improve communications and collaborations with HTCs.

Expert Faculty

Shannon Carpenter, MD, MS
Professor of Pediatrics, UMKC School of Medicine Hematology/Oncology, Director Kansas City Regional Hemophilia Treatment Center
Director, Anticoagulation Management Program
Children’s Mercy Hospital

Jay Bryant-Wimp RPh
Owner/CEO
Accurate Rx Pharmacy

John Fox, MD, MHA
Vice President, Associate Chief Medical Officer
Medical Affairs
Priority Health

And don’t miss this presentation by:

Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/insights

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Medical Education Resources.
This activity is supported by an independent educational grant from Shire, CSL Behring, and Novo Nordisk, Inc.


Quick CE Activity for Nurses, Pharmacists, and Physicians

Up to  0.5 credit hours available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

  • Discuss the unique Medicaid considerations for the coverage, reimbursement, and cost management of hemophilia services
  • Evaluate various programs that States are implementing to manage the care and costs for patients with hemophilia

Expert Faculty

Matthew Dull
Vice President, Government Analytics
Artia Solutions

 

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/medicaidmanagement

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by an independent educational grant from Shire.


Coordinating Care Management Efforts with the HTC  to Optimize Outcomes

Quick CE Activity for Nurses, Pharmacists, and Physicians

Up to  0.5 credit hours available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

  • Describe the integrated and coordinated care that is provided by hemophilia treatment centers (HTCs)
  • Apply processes for managed care organizations and specialty pharmacy providers to improve communications and collaborations with HTCs

Expert Faculty

Vanita Pindolia, PharmD, BCPS, MBA
Vice President, Ambulatory
Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health Alliance Plan of Michigan

 

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/casemanagement

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by an independent educational grant from Shire.


Free CE Activity for Nurses, Pharmacists, and Physicians

Up to  1.25 credit hours available

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

  • Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
  • Align recently approved therapies into the current hemophilia treatment algorithm
  • Explain hemophilia‐related complications associated with inhibitor development and its significant clinical and economic consequences
  • Apply processes for managed care organizations and specialty pharmacy providers to improve communications and collaborations with hemophilia treatment centers (HTCs)

Expert Faculty

Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center

Michael Zeglinski, RPh
Senior Vice President, Specialty Pharmacy 
OptumRx®/BriovaRx®

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/costmanagement

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by independent educational grants from Novo Nordisk, Inc., CSL Behring, and Shire.


Free CE Activity for Pharmacists

Certified for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education. 

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to…

  • Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options
  • Review alignment of recently approved therapies in the current hemophilia treatment algorithm
  • Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences
  • Apply processes for specialty pharmacy providers to improve communications and collaborations with hemophilia treatment centers (HTCs)

Expert Faculty

Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center

Michael Zeglinski, RPh
Senior Vice President, Specialty Pharmacy 
OptumRx®/BriovaRx®

For complete CE information and to register for this activity, please go to:
https://www.managedcarehemo.com/specialty

Jointly provided by the National Hemophilia Foundation, Impact Education, LLC, and Postgraduate Institute for Medicine.
This activity is supported by independent educational grants from Shire and CSL Behring.